电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

Recombinant Trop2 (Sacituzumab Biosimilar) 抗体

This anti-Trop2 (Sacituzumab Biosimilar) antibody is a Humanized 单克隆 antibody detecting Trop2 (Sacituzumab Biosimilar) in FACS 和 in vivo. Suitable for 人.
产品编号 ABIN7795132
发货至: 中国
Contact our Customer Service for availability and price in your country. Contact Info

Our Local Distributor

中国
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
4A Biotech Co.,Ltd.
Tel +86 (0512) 65829739 传真 +86 (010) 6788 5057

Quick Overview for Recombinant Trop2 (Sacituzumab Biosimilar) 抗体 (ABIN7795132)

抗原

Trop2 (Sacituzumab Biosimilar)

抗体类型

Recombinant Antibody

适用

宿主

  • 4
  • 1
Humanized

克隆类型

  • 4
  • 1
单克隆

标记

  • 4
  • 1
This Trop2 (Sacituzumab Biosimilar) antibody is un-conjugated

应用范围

  • 4
  • 3
  • 1
  • 1
  • 1
  • 1
Flow Cytometry (FACS), In vivo Studies (in vivo)

质量等级

Research Grade
  • Expression System

    Mammalian cells

    原理

    Sacituzumab Biosimilar, Trop-2 Monoclonal Antibody

    产品特性

    What is sacituzumab biosimilar research grade? Sacituzumab Biosimilar uses the same protein sequences as the therapeutic antibody sacituzumab. Sacituzumab govitecan is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate used for the treatment of metastatic triple-negative breast cancer and metastatic urothelial cancer. Triple-negative breast cancer is a type of breast cancer that tests negative for estrogen receptors, progesterone receptors and human epidermal growth factor receptor 2 (HER2) protein. Therefore, triple-negative breast cancer does not respond to hormonal therapy medicines or medicines that target HER2. Sacituzumab govitecan is a conjugate of the humanized anti-Trop-2 monoclonal antibody linked with SN-38, the active metabolite of irinotecan. Each antibody having on average 7.6 Molecules of SN-38 attached. SN-38 is too toxic to administer directly to patients, but linkage to an antibody allows the drug to specifically target cells containing Trop-2.

    纯化方法

    Protein A or G affinity column

    纯度

    >95 % by reducing SDS-PAGE

    内毒素水平

    < 1 EU per 1 mg of the protein by the LAL method

    免疫原

    Human Trop-2
  • 应用备注

    Optimal working dilution should be determined by the investigator.

    限制

    仅限研究用
  • 状态

    Liquid

    浓度

    > 3 mg/mL

    储存条件

    4 °C,-20 °C

    储存方法

    Short time 2 to 8°C as supplied. Long time -20°C to -70°C as supplied.
  • 抗原

    Trop2 (Sacituzumab Biosimilar)

    别名

    Sacituzumab Biosimilar

    物质类

    Biosimilar
You are here: